The market for plant-based and alt protein continues to thrive in South Korea, where a plant-based Whopper launches into Burger King, and two domestic cell-based companies announce significant developments.
Korea’s CellMEAT Raises $13M After Developing Cultivated Shrimp & Caviar
South Korea-based cultivated seafood company CellMEAT has raised 17.4 billion KRW ($13 million) in Series A funding. The round was led by previous investors BNK Venture Investment, Ryukyung PSG Asset Management, and Strong Ventures. Three new investors — NH Venture Investment, Genting Ventures, and Daewoodang Healthcare — also participated. It comes as CellMEAT prepares to officially open a mass production center in Seoul later this month, after developing cell culture technology that makes large-scale production economically viable. The company is notable for being one of the first worldwide to develop a serum-free cell culture medium, helping to bring down the cost of production while removing the ethical issues associated with fetal bovine serum. Prioritizing technology development CellMEAT previously raised $8.1 million in a funding round …